English
Deutsch
Español
Français
Italiano
Polski
Português
Română
Русский
繁體中文

Yoga Instructor Kevin Naidoo Discusses Vision Improvements After Stem Cell Treatment [Video]

⏲️2 minutes read

Kevin Naidoo, a yoga instructor from Saskatoon, Canada recently returned home from his stem cell treatment “adventure” in Bangkok, Thailand to treat his Optic Nerve Atrophy (ONA) which was caused by Glaucoma, which is an increase of intra-ocular pressure that can damage the optic nerve. His treatment utilized adult stem cells and treatment protocols from Beike Biotechnology.

Kevin’s father researched the condition thoroughly and spending countless hours and nights on the internet and phone until finding Beike Biotechnology‘s stem cell research and protocols and brought this to Kevin Naidoo who was willing to give the therapy a try.

This sparked a fundraising campaign which led to much news coverage also gave Kevin Naidoo a platform in which to share his story and the disappointment that many others face when confronted with conditions such as Glaucoma. At diagnosis, Kevin was told that there were no substantial therapies available in North America and that a condition like Glaucoma is something you just “go home and get comfortable with.”

Kevin Naidoo Talks Glaucoma Improvements

After the vision in his left eye degenerated until complete blindness, Kevin Naidoo was diagnosed with open angular glaucoma. Besides the vision in his left eye being completely gone, according to him the glaucoma has also reduced his vision to “pretty much 50 per cent of [his] right eye.” Fellow Canadian, Glaucoma patient, and lifelong vision impairment sufferer Janice Marks also received the same treatment in Thailand – one she learned about through Kevin Naidoo’s story.

Watch now: Kevin Naidoo and Janice Undergo Adult Stem Cell Treatment for Glaucoma

Pre-treatment Articles:

Saskatoon yoga instructor Kevin Naidoo fighting to save his vision

Blind Saskatoon yoga instructor looking to regain sight through stem cell treatment

Below are Kevin and Janice’s Treatment Protocols:

Kevin Naidoo
Diagnosis: Open Angular Glaucoma
Cell Type: Six (6) Packs – Umbilical Cord Blood Stem Cells (UCBSC)
Injection Methods: Retrobulbar (RB), Intravenous (IV), & Lumbar Puncture (LP)
Additional Therapies: Transcranial Magnetic Stimulation, Acupuncture, Hyperbaric Oxygen Therapy, Occupational Therapy

Janice Marks
Diagnosis: Optic Nerve Atrophy (ONA)
Cell Type: Eight (8) Packs – Umbilical Cord Blood Stem Cells (UCBSC)
Injection Methods: Retrobulbar (RB), Intravenous (IV), & Lumbar Puncture (LP)
Additional Therapies: Transcranial Magnetic Stimulation, Acupuncture, Hyperbaric Oxygen Therapy, Occupational Therapy

For more information regarding our visual impairment stem cell treatment protocols please inquire below.

Inquire for Stem Cell Treatment

References

  1. Yiming Huang & Volker Enzmann & Suzanne T. Ildstad. Stem Cell-Based Therapeutic Applications in Retinal Degenerative Diseases. Stem Cell Rev and RepDOI 10.1007/s12015-010-9192-8.
  2. Pinilla I, Martin Nieto J, Cuenca N. Stem Cell Potential Uses in Retinal Dystrophies. Arch Sic Esp Oftalmol 2007; 82: 127-128.
  3. Paul S. Baker and Gary C. Brown. Stem-cell therapy in retinal disease. Current Opinion in Ophthalmology 2009, 20:175–181.
  4. Isabel Zwart, Andrew J. Hill, Faisal Al-Allaf et al. Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model. Experimental Neurology 216 (2009) 439–448.
  5. Annegret Dahlmann-Noon et al. Current approaches and future prospects for stem cell rescue and regeration of retina and optic nerve. can J Ophthalmol 2010;45:333-41.
  6. Naoko Koike Kiriyama et al. Human cord blood stem cells can differentiate into retinal nerve cells. Acta Neurobiol Exp 2007, 67;359-365.
  7. Rubens Camargo SiqueiraI; Júlio Cesar Voltarelli; André Marcio Vieira Messias; Rodrigo Jorge. Possible mechanisms of retinal function recovery with the use of cell therapy with bone marrow-derived stem cells.
  8. Tantai Zhao & Yunqin Li & Luosheng Tang et al. Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats. Graefes Arch Clin Exp Ophthalmol DOI 10.1007/s00417-011-1635-7.